Eamonn Hobbs

Chief Executive Officer at Syncromune.

Earliest Form D on file: May 2026

Filed May 11, 2026Amendment

Syncromune

Cryoablation-based immunotherapy for prostate cancer

Biotech, Fort Lauderdale FL

Signed as Chief Executive Officer

$144.8M

sold of $144.8M offered

Reported on an amendment to an earlier filing.

Network

At Syncromune

9 people

Charles J. Link
Executive Officer, Director
Agustin Gago
Executive Officer
Douglas G. Watson
Director
JEFFREY CLELAND
Director
Joseph C. Maroon
Director
Joseph Gerardi
Executive Officer

3 more at Syncromune